The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...

Scientists have long thought that only one species of tick found in the United States, the lone star tick, could […] ...

A patch test for atopic dermatitis helps identify triggers and confirms diagnosis. Learn about self-testing and specialists ...

BioMarin Pharmaceutical Inc. today announced that the Phase 3 PEGASUS trial evaluating PALYNZIQ® (pegvaliase-pqpz) met its primary efficacy endpoint, demonstrating a statistically significant lowering ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III MUSETTE trial comparing a high dose of Ocrevus® (ocrelizumab) intravenous (IV) infusion to the ...

You have atopic dermatitis, better known as eczema. According to the National Eczema Association, more than 31 million people in the United States alone experience this genetic skin condition.